Eduardo Tolosa

51.4k total citations · 7 hit papers
386 papers, 26.6k citations indexed

About

Eduardo Tolosa is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Eduardo Tolosa has authored 386 papers receiving a total of 26.6k indexed citations (citations by other indexed papers that have themselves been cited), including 317 papers in Neurology, 100 papers in Cellular and Molecular Neuroscience and 62 papers in Neurology. Recurrent topics in Eduardo Tolosa's work include Parkinson's Disease Mechanisms and Treatments (271 papers), Neurological disorders and treatments (190 papers) and Botulinum Toxin and Related Neurological Disorders (51 papers). Eduardo Tolosa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (271 papers), Neurological disorders and treatments (190 papers) and Botulinum Toxin and Related Neurological Disorders (51 papers). Eduardo Tolosa collaborates with scholars based in Spain, United Kingdom and United States. Eduardo Tolosa's co-authors include Werner Poewe, Francesc Valldeoriola, Marı́a José Martı́, Carme Junqué, Olivier Rascol, Joan Santamaría, Yaroslau Compta, Carles Gaig, Alícia Garrido and Gregor K. Wenning and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Eduardo Tolosa

378 papers receiving 25.9k citations

Hit Papers

Clinical research criteri... 1996 2026 2006 2016 1996 2013 2021 2005 2009 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
    1996 2.0k citations Joseph Jankovic, Eduardo Tolosa et al. Neurology profile →
  2. Criteria for the diagnosis of corticobasal degeneration
    2013 1.2k citations Eduardo Tolosa et al. Neurology profile →
  3. Challenges in the diagnosis of Parkinson's disease
    2021 1.0k citations Eduardo Tolosa, Alícia Garrido et al. profile →
  4. The diagnosis of Parkinson's disease
    2005 624 citations Eduardo Tolosa, Werner Poewe et al. profile →
  5. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
    2009 587 citations C. Warren Olanow, Olivier Rascol et al. profile →
  6. LRRK2 in Parkinson disease: challenges of clinical trials
    2020 301 citations Eduardo Tolosa, Miquel Vila et al. profile →
  7. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
    2019 267 citations Angelique di Domenico, Giulia Carola et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Tolosa Spain 84 19.8k 6.5k 4.7k 4.0k 3.6k 386 26.6k
Charles H. Adler United States 73 19.5k 1.0× 5.3k 0.8× 4.3k 0.9× 4.7k 1.2× 2.9k 0.8× 313 25.7k
Wolfgang H. Oertel Germany 71 15.9k 0.8× 6.0k 0.9× 3.6k 0.8× 2.8k 0.7× 3.1k 0.9× 292 23.4k
Olivier Rascol France 86 20.8k 1.1× 7.7k 1.2× 4.7k 1.0× 2.1k 0.5× 3.0k 0.8× 434 27.5k
Daniela Berg Germany 83 19.8k 1.0× 6.8k 1.1× 2.9k 0.6× 4.6k 1.2× 4.2k 1.2× 533 29.2k
Christopher G. Goetz United States 96 27.4k 1.4× 8.6k 1.3× 6.9k 1.5× 3.5k 0.9× 3.3k 0.9× 431 36.6k
José Á. Obeso Spain 78 21.1k 1.1× 10.8k 1.7× 5.3k 1.1× 2.5k 0.6× 3.8k 1.1× 308 29.1k
Klaus Seppi Austria 70 16.3k 0.8× 6.0k 0.9× 2.7k 0.6× 2.5k 0.6× 2.6k 0.7× 296 21.1k
Gregor K. Wenning Austria 84 23.4k 1.2× 10.4k 1.6× 2.5k 0.5× 4.7k 1.2× 5.9k 1.6× 418 29.6k
David J. Burn United Kingdom 91 18.1k 0.9× 4.3k 0.7× 4.8k 1.0× 4.5k 1.1× 2.9k 0.8× 378 26.5k
Irene Litvan United States 77 24.8k 1.3× 6.7k 1.0× 5.0k 1.1× 7.3k 1.8× 5.4k 1.5× 337 33.4k

Countries citing papers authored by Eduardo Tolosa

Since Specialization
Citations

This map shows the geographic impact of Eduardo Tolosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Tolosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Tolosa more than expected).

Fields of papers citing papers by Eduardo Tolosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Tolosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Tolosa. The network helps show where Eduardo Tolosa may publish in the future.

Co-authorship network of co-authors of Eduardo Tolosa

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Tolosa. A scholar is included among the top collaborators of Eduardo Tolosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Tolosa. Eduardo Tolosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pons‐Espinal, Meritxell, Irene Fernández‐Carasa, Pol Andrés‐Benito, et al.. (2024). Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease. JCI Insight. 9(3). 21 indexed citations
2.
Iranzo, Álex, Morten Gersel Stokholm, Erik Hvid Danielsen, et al.. (2024). Microglial Activation and Progression of Nigrostriatal Dysfunction in Isolated REM Sleep Behavior Disorder. Movement Disorders. 39(8). 1323–1328. 6 indexed citations
3.
Lees, Andrew J., Eduardo Tolosa, Fabrizio Stocchi, et al.. (2023). Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach. Expert Review of Neurotherapeutics. 23(1). 15–24. 25 indexed citations
4.
Fernández, Manel, Alícia Garrido, María Sierra, et al.. (2023). Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease. npj Parkinson s Disease. 9(1). 15–15. 7 indexed citations
5.
Iranzo, Álex, Morten Gersel Stokholm, Erik Hvid Danielsen, et al.. (2023). Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder. European Journal of Neurology. 31(1). e16101–e16101. 14 indexed citations
6.
Tolosa, Eduardo, et al.. (2023). Steel Corrosion in Highly Carbonated Solutions Mitigated Using Biphosphate Ions as Inhibiting Agents. Journal of The Electrochemical Society. 170(3). 31501–31501. 1 indexed citations
7.
Garrido, Alícia, Graham Fairfoul, Eduardo Tolosa, et al.. (2022). Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PD. Movement Disorders. 38(2). 333–338. 17 indexed citations
8.
Garrido, Alícia, Cristina Simonet, Núria Martín‐Flores, et al.. (2022). Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers. Annals of Neurology. 92(5). 888–894. 1 indexed citations
9.
Brown, Ethan, David Alonso–Gutiérrez, Lana M. Chahine, et al.. (2022). Parkinson’s Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson’s disease (PD) (P9-11.006). Neurology. 98(18_supplement). 2 indexed citations
10.
Nissen, Sara Konstantin, Morten Gersel Stokholm, Álex Iranzo, et al.. (2021). Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder. Proceedings of the National Academy of Sciences. 118(10). 47 indexed citations
11.
Carola, Giulia, Carles Calatayud, Meritxell Pons‐Espinal, et al.. (2021). Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration. npj Parkinson s Disease. 7(1). 55–55. 20 indexed citations
12.
Podlesniy, Petar, Núria Serra, Rubén Fernández‐Santiago, et al.. (2019). Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease. EBioMedicine. 48. 554–567. 27 indexed citations
13.
Recasens, Ariadna, Iria Carballo‐Carbajal, Annabelle Parent, et al.. (2018). Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients. Acta Neuropathologica Communications. 6(1). 8–8. 20 indexed citations
14.
Martínez‐Martín, Pablo, Jaime Kulisevsky, Pablo Mir, et al.. (2018). Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire. npj Parkinson s Disease. 4(1). 20–20. 22 indexed citations
15.
Luquín, M. R., Jaime Kulisevsky, Pablo Martínez‐Martín, Pablo Mir, & Eduardo Tolosa. (2017). Consensus on the Definition of Advanced Parkinson’s Disease: A Neurologists-Based Delphi Study (CEPA Study). Parkinson s Disease. 2017. 1–8. 72 indexed citations
16.
Jankovic, Joseph & Eduardo Tolosa. (2015). Parkinson's disease & movement disorders. 19 indexed citations
17.
Rascol, Olivier, Paolo Barone, Madhuri Behari, et al.. (2012). Perampanel in Parkinson Disease Fluctuations. Clinical Neuropharmacology. 35(1). 15–20. 45 indexed citations
18.
Iranzo, Álex, Birgit Frauscher, Helena Santos, et al.. (2011). Usefulness of the SINBAR electromyographic montage to detect the motor and vocal manifestations occurring in REM sleep behavior disorder. Sleep Medicine. 12(3). 284–288. 76 indexed citations
19.
Katzenschlager, Regina, et al.. (2003). Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. Movement Disorders. 18(10). 1123–1131. 19 indexed citations
20.
Pástor, Pau & Eduardo Tolosa. (2002). Progressive supranuclear palsy: clinical and genetic aspects. Current Opinion in Neurology. 15(4). 429–437. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles H. Adler Breakdown of academic impact, for papers by Wolfgang H. Oertel Breakdown of academic impact, for papers by Olivier Rascol Breakdown of academic impact, for papers by Daniela Berg Breakdown of academic impact, for papers by Christopher G. Goetz Breakdown of academic impact, for papers by José Á. Obeso Breakdown of academic impact, for papers by Klaus Seppi Breakdown of academic impact, for papers by Gregor K. Wenning Breakdown of academic impact, for papers by David J. Burn Breakdown of academic impact, for papers by Irene Litvan
Rankless by CCL
2026